Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Appl Environ Microbiol ; 66(9): 3705-10, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10966380

ABSTRACT

Pseudomonas oleovorans is capable of producing poly(3-hydroxyalkanoates) (PHAs) as intracellular storage material. To analyze the possible involvement of phaD in medium-chain-length (MCL) PHA biosynthesis, we generated a phaD knockout mutant by homologous recombination. Upon disruption of the phaD gene, MCL PHA polymer accumulation was decreased. The PHA granule size was reduced, and the number of granules inside the cell was increased. Furthermore, mutant cells appeared to be smaller than wild-type cells. Investigation of MCL PHA granules revealed that the pattern of granule-associated proteins was changed and that the predominant protein PhaI was missing in the mutant. Complementation of the mutant with a phaD-harboring plasmid partially restored the wild-type characteristics of MCL PHA production and fully restored the granule and cell sizes. Furthermore, PhaI was attached to the granules of the complemented mutant. These results indicate that the phaD gene encodes a protein which plays an important role in MCL PHA biosynthesis. However, although its main effect seems to be the stabilization of MCL PHA granules, we found that the PhaD protein is not a major granule-associated protein and therefore might act by an unknown mechanism involving the PhaI protein.


Subject(s)
Bacterial Proteins/metabolism , Polymers/metabolism , Pseudomonas/metabolism , Amino Acid Sequence , Bacterial Proteins/genetics , Gene Deletion , Genes, Bacterial , Genetic Complementation Test , Microscopy, Electron , Molecular Sequence Data , Mutation , Polymers/chemistry , Pseudomonas/genetics , Pseudomonas/growth & development
2.
Appl Environ Microbiol ; 66(3): 909-13, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10698750

ABSTRACT

Medium-chain-length (mcl) poly(3-hydroxyalkanoates) (PHAs) are storage polymers that are produced from various substrates and accumulate in Pseudomonas strains belonging to rRNA homology group I. In experiments aimed at increasing PHA production in Pseudomonas strains, we generated an mcl PHA-overproducing mutant of Pseudomonas putida KT2442 by transposon mutagenesis, in which the aceA gene was knocked out. This mutation inactivated the glyoxylate shunt and reduced the in vitro activity of isocitrate dehydrogenase, a rate-limiting enzyme of the citric acid cycle. The genotype of the mutant was confirmed by DNA sequencing, and the phenotype was confirmed by biochemical experiments. The aceA mutant was not able to grow on acetate as a sole carbon source due to disruption of the glyoxylate bypass and exhibited two- to fivefold lower isocitrate dehydrogenase activity than the wild type. During growth on gluconate, the difference between the mean PHA accumulation in the mutant and the mean PHA accumulation in the wild-type strain was 52%, which resulted in a significant increase in the amount of mcl PHA at the end of the exponential phase in the mutant P. putida KT217. On the basis of a stoichiometric flux analysis we predicted that knockout of the glyoxylate pathway in addition to reduced flux through isocitrate dehydrogenase should lead to increased flux into the fatty acid synthesis pathway. Therefore, enhanced carbon flow towards the fatty acid synthesis pathway increased the amount of mcl PHA that could be accumulated by the mutant.


Subject(s)
Isocitrate Lyase/deficiency , Polyesters/metabolism , Pseudomonas putida/metabolism , Gluconates/metabolism , Glyoxylates/metabolism , Heptanoates/metabolism , Isocitrate Lyase/genetics , Models, Biological , Mutagenesis, Insertional , Mutation
3.
Cell Microbiol ; 2(2): 173-85, 2000 Apr.
Article in English | MEDLINE | ID: mdl-11207574

ABSTRACT

Yersinia enterocolitica cross the intestinal epithelium via translocation through M cells, which are located in the follicle-associated epithelium (FAE) of Peyer's patches (PP). To investigate the molecular basis of this process, studies were performed using a recently developed in vitro model, in which the enterocyte-like cell line Caco-2 and PP lymphocytes are co-cultured in order to establish FAE-like structures including M cells. Here, we demonstrate that Y. enterocolitica does not adhere significantly to the apical membrane of differentiated enterocyte-like Caco-2 cells that express binding sites for Ulex europaeus agglutinin (UEA)-1. In contrast, Y. enterocolitica adhered to, and was internalized by, cells that lacked UEA-1 binding sites and displayed a disorganized brush border. These cells were considered to be converted to M-like cells. Further analysis revealed that part of these cells expressed beta1 integrins at their apical surface and, as revealed by comparison of wild-type and mutant strains, interacted with invasin of Y. enterocolitica. Consistently, anti-beta1 integrin antibodies significantly inhibited internalization of inv-expressing yersiniae. Experiments with Yersinia mutant strains deficient in YadA or Yop secretion revealed that these virulence factors play a minor role in this process. After internalization, yersiniae were transported within LAMP-1-negative vacuoles to, and released at, the basal surface. Internalization and transport of yersiniae was inhibited by cytochalasin D, suggesting that F-actin assembly is required for this process. These results provide direct evidence that expression of beta1 integrins at the apical surface of M cells enables interaction with the invasin of Y. enterocolitica, and thereby initiates internalization and translocation of bacteria.


Subject(s)
Adhesins, Bacterial , Bacterial Proteins/metabolism , Epithelial Cells/microbiology , Integrin beta1/metabolism , Intestinal Mucosa/microbiology , Yersinia enterocolitica/pathogenicity , Bacterial Adhesion , Caco-2 Cells , Coculture Techniques , Humans , Intestinal Mucosa/cytology , Lymphocytes/microbiology , Microscopy, Electron , Microscopy, Fluorescence , Yersinia Infections/microbiology , Yersinia enterocolitica/genetics , Yersinia enterocolitica/physiology
4.
Dtsch Med Wochenschr ; 124(25-26): 783-7, 1999 Jun 25.
Article in German | MEDLINE | ID: mdl-10414227

ABSTRACT

BACKGROUND AND OBJECTIVE: Resistance against activated protein C (APC), caused by factor V R506Q mutation (factor V Leiden mutation), is among the most important hereditary clotting defects that are associated with an increased risk of venous thrombosis. As there are hardly any data for Germany regarding APC resistance that have been validated by genetic analysis, this study was undertaken to determine the prevalence of factor V Leiden (fVL) mutations in a sizeable group of patients in Germany with venous thromboembolism (VTE) and a control group of healthy persons. PATIENTS AND METHODS: 1200 consecutive patients (689 females, 511 males) from various regions of Germany were examined who, at an age between 0.1 and 45 years, had developed primary deep vein thrombosis (DVT) and/or pulmonary embolism (PE), as confirmed by imaging tests. The control group consisted of 740 healthy persons (332 females and 408 males; median age 33 years) for whom there was no evidence in their personal or family history of TE. Analysis of the fV-1691 genotype was by Mnll-restriction analysis of genomic fV DNA fragments, amplified by polymerase chain reaction. RESULTS: The prevalence in the control group was 7.5% the for heterozygotic fV:Q506 mutant (25 females, 30 males). For the patients the prevalence of the fV R506Q mutation was 27.2% (32.1% heterozygotes [165 females, 112 males]; 4.1% homozygotes [33 females, 16 males], i.e. significantly higher than in the healthy controls (P < 0.0001). In 81.3% of the patients with fV:Q506 DVT in the leg-pelvic vein region was found as the first manifestation, thrombosis in an atypical site in 14.4% and isolated PE in 4.3%. The first manifestation had occurred spontaneously in 36% of patients with the fV:Q506 mutant (44 females, 75 males), in 53.1% of homozygotes and in 33.5% of heterozygotic carriers of the mutation. CONCLUSION: The fV Leiden mutation due to APC resistance is the most common cause of venous thrombosis and apparently one of the most common inherited diseases.


Subject(s)
Activated Protein C Resistance/epidemiology , Factor V/genetics , Point Mutation , Venous Thrombosis/epidemiology , Activated Protein C Resistance/genetics , Adolescent , Adult , Child , Child, Preschool , DNA/analysis , DNA/chemistry , Female , Germany/epidemiology , Heterozygote , Homozygote , Humans , Infant , Male , Middle Aged , Polymerase Chain Reaction , Prevalence , Pulmonary Embolism/epidemiology , Pulmonary Embolism/genetics , Restriction Mapping , Venous Thrombosis/genetics
5.
Appl Environ Microbiol ; 65(2): 540-8, 1999 Feb.
Article in English | MEDLINE | ID: mdl-9925580

ABSTRACT

It was shown recently that recombinant Escherichia coli, defective in the beta-oxidation cycle and harboring a medium-chain-length (MCL) poly(3-hydroxyalkanoate) (PHA) polymerase-encoding gene of Pseudomonas, is able to produce MCL PHA from fatty acids but not from sugars or gluconate (S. Langenbach, B. H. A. Rehm, and A. Steinbüchel, FEMS Microbiol. Lett. 150:303-309, 1997; Q. Ren, Ph.D. thesis, ETH Zürich, Zürich, Switzerland, 1997). In this study, we report the formation of MCL PHA from gluconate by recombinant E. coli. By introduction of genes coding for an MCL PHA polymerase and the cytosolic thioesterase I ('thioesterase I) into E. coli JMU193, we were able to engineer a pathway for the synthesis of MCL PHA from gluconate. We used two expression systems, i.e., the bad promoter and alk promoter, for the 'thioesterase I- and PHA polymerase-encoding genes, respectively, which enabled us to modulate their expression independently over a range of inducer concentrations, which resulted in a maximum MCL PHA accumulation of 2.3% of cell dry weight from gluconate. We found that the amount of PHA and the 'thioesterase I activity are directly correlated. Moreover, the polymer accumulated in the recombinant E. coli consisted mainly of 3-hydroxyoctanoate monomers. On the basis of our data, we propose an MCL PHA biosynthesis pathway scheme for recombinant E. coli JMU193, harboring PHA polymerase and 'thioesterase I, when grown on gluconate, which involves both de novo fatty acid synthesis and beta-oxidation.


Subject(s)
Bacterial Proteins , Escherichia coli/genetics , Escherichia coli/metabolism , Gluconates/metabolism , Polyesters/metabolism , Acyltransferases/genetics , Acyltransferases/metabolism , DNA, Recombinant , Gene Expression Regulation, Bacterial , Gene Expression Regulation, Enzymologic , Palmitoyl-CoA Hydrolase/genetics , Palmitoyl-CoA Hydrolase/metabolism , Promoter Regions, Genetic
9.
Appl Environ Microbiol ; 62(3): 749-55, 1996 Mar.
Article in English | MEDLINE | ID: mdl-16535265

ABSTRACT

Rhodococcus rhodochrous PB1 was isolated from compost soil by selective culture with racemic 3-phenylbutyric acid as the sole carbon and energy source. Growth experiments with the single pure enantiomers as well as with the racemate showed that only one of the two enantiomers, (R)-3-phenylbutyric acid, supported growth of strain PB1. Nevertheless, (S)-3-phenylbutyric acid was cometabolically transformed to, presumably, (S)-3-(2,3-dihydroxyphenyl)butyric acid (the absolute configuration at the C-3 atom is not known yet) by (R)-3-phenylbutyric acid-grown cells of strain PB1, as shown by (sup1)H nuclear magnetic resonance spectroscopy of the partially purified compound and gas chromatography-mass spectrometry analysis of the trimethylsilyl derivative. Oxygen uptake rates suggest that either 3-phenylpropionic acid or cinnamic acid (trans-3-phenyl-2-propenoic acid) is the substrate for aromatic ring hydroxylation. This view is substantiated by the fact that 3-(2,3-dihydroxyphenyl)propionic acid was a substrate for meta cleavage in cell extracts of (R)-3-phenylbutyric acid-grown cells of strain PB1. Gas chromatography-mass spectrometry analysis of trimethylsilane-treated ethyl acetate extracts of incubation mixtures showed that both the meta-cleavage product, 2-hydroxy-6-oxo-2,4-nonadiene-1,9-dicarboxylic acid, and succinate, a hydrolysis product thereof, were formed during such incubations.

10.
J Bacteriol ; 178(1): 314-6, 1996 Jan.
Article in English | MEDLINE | ID: mdl-8550437

ABSTRACT

Heterofermentative gram-positive bacteria are believed to metabolize sugars exclusively via the pentose phosphoketolase pathway following uptake via sugar:cation symport. Here we show that anaerobic growth of one such bacterium, Lactobacillus brevis, in the presence of fructose induces the synthesis of a phosphotransferase system and glycolytic enzymes that allow fructose to be metabolized via the Embden-Meyerhof pathway.


Subject(s)
Bacterial Proteins , Fermentation , Fructose/metabolism , Lactobacillus/enzymology , Phosphoenolpyruvate Sugar Phosphotransferase System/metabolism , Aerobiosis , Anaerobiosis , Fructose-Bisphosphate Aldolase/metabolism , Glycolysis , Lactobacillus/metabolism , Phosphofructokinase-1/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...